No Data
Thermo Fisher Is Maintained at Equal-Weight by Barclays
Thermo Fisher Scientific Analyst Ratings
Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?
Thermo Fisher Scientific Introduces Biobased Solutions to Help Reduce Climate Impact in Manufacturing of Therapies
Express News | Thermo Fisher Scientific : Barclays Cuts Target Price to $600 From $615
Barclays Maintains Thermo Fisher Scientific(TMO.US) With Hold Rating, Cuts Target Price to $600
Barclays analyst Luke Sergott maintains $Thermo Fisher Scientific(TMO.US)$ with a hold rating, and adjusts the target price from $615 to $600.According to TipRanks data, the analyst has a success rate